BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

Clinical trial NCT06383013 · RECRUITING

Trial details

NCT number: NCT06383013
Sponsor: Blue Blood Biotech Corp.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Foot Ulcer

Start date: 2024-05-01
Primary completion: 2027-12-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.